Target intelligence / Profile preview

Extracellular calcium–phosphate equilibrium

Molecular classification
G protein-coupled receptor, Nuclear receptor, Hormone, Transporter
01

Overview

Extracellular calcium–phosphate equilibrium refers to the tightly regulated physiological process that maintains stable concentrations of ionized calcium and inorganic phosphate in the blood and extracellular fluid (StatPearls, 2023). This homeostasis is critical for skeletal integrity, nerve conduction, muscle contraction, and cellular metabolism (NIH, 2022). It is primarily governed by a complex feedback loop involving the parathyroid glands, kidneys, bone, and intestines, mediated by hormones such as parathyroid hormone (PTH), calcitriol (active vitamin D), and fibroblast growth factor 23 (FGF23) (PubMed, 2021). Dysregulation of this equilibrium is a hallmark of chronic kidney disease-mineral and bone disorder (CKD-MBD), leading to complications like vascular calcification and metabolic bone disease (Journal of Nephrology, 2020). While the equilibrium itself is a physiological state rather than a single protein, it is managed pharmacologically by targeting specific receptors and transporters like the calcium-sensing receptor (CaSR) and sodium-phosphate cotransporters (Nature Reviews Nephrology, 2019).

Other names
Calcium-phosphate homeostasisMineral metabolismCalcium-phosphorus balanceMineral homeostasis
02

Mechanism of action

Modulation of parathyroid hormone secretion via the calcium-sensing receptor, inhibition of intestinal phosphate absorption, regulation of renal phosphate reabsorption, and activation of vitamin D receptors.

03

Biological functions

Mineral homeostasisBone remodelingNeuromuscular signalingCellular metabolismSignal transduction
04

Disease associations

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)HyperparathyroidismHypoparathyroidismOsteoporosisVascular calcificationRickets
05

Safety considerations

HypocalcemiaHypercalcemiaVascular calcificationAdynamic bone diseaseGastrointestinal intolerance
06

Interacting drugs

Cinacalcet

6 more in the full profile.

07

Biomarkers

Serum ionized calciumSerum inorganic phosphateIntact parathyroid hormone (iPTH)Fibroblast growth factor 23 (FGF23)Bone-specific alkaline phosphatase

Beyond the preview

Go deeper on Extracellular calcium–phosphate equilibrium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular calcium–phosphate equilibrium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call